Targeting Estrogen Receptor Sites in Human Breast Cancer Cell Line T47D with Copper Conjugates of Nonsteroidal Anti-Inflammatory Drug Derivatives: Antiproliferative Activity of Toprofen Derivative and Its Copper Complex
2001
Targeting Estrogen Receptor Sites in Breast Cancer with Copper Conjugates
publication
Evidence: moderate
Author Information
Author(s): Dilip Kumar Saha, Shreelekha Padhye, Subhash Padhye
Primary Institution: Department of Chemistry, University of Pune, India
Hypothesis
Can copper complexes of NSAID derivatives enhance antiproliferative activity against breast cancer cells?
Conclusion
The copper complex of ketoprofen thiosemicarbazone shows enhanced antiproliferative effects on T47D breast cancer cells.
Supporting Evidence
- The copper complex showed dose-dependent inhibition of DNA synthesis in T47D cells.
- Complexation with copper lowered the IC50 value of the ligand, indicating enhanced efficacy.
- The study suggests that copper ions may selectively bind to estrogen receptors in cancer cells.
Takeaway
Researchers created a special copper compound that helps fight breast cancer cells better than regular drugs.
Methodology
The study involved synthesizing a copper complex of ketoprofen thiosemicarbazone and testing its effects on T47D breast cancer cells.
Want to read the original?
Access the complete publication on the publisher's website